Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Pre-transplant and post-transplant sCD30 levels, tnf-alpha and sIL-2r as risk factors for renal allograft rejection (CROSBI ID 522545)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Humar, Ines ; Puretić, Zvonimir ; Goreta, Nedjeljka ; Puc, Maja ; Mihaljević, Željko ; Pasini, Josip ; Brkljačić-Kerhin, Vesna Pre-transplant and post-transplant sCD30 levels, tnf-alpha and sIL-2r as risk factors for renal allograft rejection // Transplantation proceedings. 2006

Podaci o odgovornosti

Humar, Ines ; Puretić, Zvonimir ; Goreta, Nedjeljka ; Puc, Maja ; Mihaljević, Željko ; Pasini, Josip ; Brkljačić-Kerhin, Vesna

engleski

Pre-transplant and post-transplant sCD30 levels, tnf-alpha and sIL-2r as risk factors for renal allograft rejection

Allograft rejection is associated with T cell activation. T cell activation leads to secretion and elevated serum soluble IL-2 receptor (sIL-2R) levels. The CD30 molecule, a member of the tumor necrosis factor receptor family, is preferentially expressed on human CD4+ and CD8+ T cells. A soluble form of CD30 (sCD30) is released into the blood following immune activation. In the present study we evaluated whether the presence of serum sCD30 correlated with clinical events following renal transplantation (Tx). The pre and post Tx sera (day 4, - 8, - 14 and - 30) of 127 primary recipients of a deceased donor renal allograft were tested for the presence of sCD30 (U/ml), sIL-2R (U/ml), TNF- (pg/ml) using an ELISA kits. For statistical difference Cox regression was used. Immunological risk factors (PRA 12, 60% and HLA MM 2, 8 1, 1) had no impact. The results were correlated with graft rejection, survival and degree of recipient sensitization. The presence of HLA Ab is thought to be an immunological risk factor in renal transplantation. Due to small number recipients with PRA, where was not association with sCD30 and graft rejection. High sCD30 was associated with poor graft survival and rejection. The pre Tx sCD30 for recipients experiencing rejections was greater than the sCD30 for non-rejecting recipients (370 93, 6 vs. 165 32, 97 U/ml, P=0.002). Post Tx sCD30 was significant on day 8 at the level of significance P=0, 028 (rejection vs. non-rejection). Differences of sCD30 were present with no significance on day 4, 14 and 30. Recipients undergoing severe rejection episodes had higher overall serum levels of sIL-2R on day 4 (449 115, 46 U/ml vs. 240, 88 53, 45 U/ml) as compared with recipients who had stable renal function and no episodes of rejection (P= 0.027). Comparison of sIL-2R ratios (posttransplant sIL-2R level/pre-transplant sIL-2R level) revealed that ratios of 0.6 or higher were more frequently seen in patients who subsequently underwent severe rejection episodes. TNF- was significantly different pre Tx (P=0, 012) and on day 8 (P=0.0307). Independent of classical immunological risk factors, these data suggest that high level of sCD30 and TNF- (members of the tumor necrosis factor family) reflect an immunological risk for rejection while sIL-2R maybe predictive of severe rejection episodes. Moreover, serial monitoring may identify changes that correlate with post Tx clinical events.

Kidney transplantation; monitoring; rejection; T cell activation

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

2006.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Transplantation proceedings

0041-1345

Podaci o skupu

World Transplant Congress (1 ; 2006)

poster

22.07.2006-27.07.2006

Boston (MA), Sjedinjene Američke Države

Povezanost rada

Temeljne medicinske znanosti

Indeksiranost